Casodex (bicalutamide) 150-mg monotherapy compared with castration in patients with previously untreated nonmetastatic prostate cancer: results from two multicenter randomized trials at a median follow-up of 4 years

Authors: Iversen P.1; Tyrrell C.J.; Kaisary A.V.; Anderson J.B.; Baert L.; Tammela T.; Chamberlain M.; Carroll K.; Gotting-Smith K.; Blackledge G.R.P.

Source: Urology, Volume 51, Number 3, March 1998 , pp. 389-396(8)

Publisher: Elsevier

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Language: English

Document Type: Short communication

DOI: 10.1016/S0090-4295(98)00004-1

Affiliations: 1: aUniversity of Copenhagen, , Copenhagen, Denmark

This article is hosted on another website.

You may be required to register, activate a subscription or purchase the article before you can obtain the full text.

Proceed

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A